According to China Resources Pharmaceutical Group's latest financial reports the company has $7.81 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $6.67 B | -9.86% |
2021-12-31 | $7.40 B | 25.27% |
2020-12-31 | $5.91 B | 18.32% |
2019-12-31 | $4.99 B | -12.35% |
2018-12-31 | $5.70 B | 115.07% |
2017-12-31 | $2.65 B | 16.78% |
2016-12-31 | $2.27 B | -5.83% |
2015-12-31 | $2.41 B | -1.55% |
2014-12-31 | $2.44 B | 12.17% |
2013-12-31 | $2.18 B |